Concepedia

L Dantis

LD

Statistics

Publications

6

Citations

2.3K

H-Index

6

Active since

1988

Affiliations

Memorial Sloan Kettering Cancer Center(Current)

L Dantis is an author at Memorial Sloan Kettering Cancer Center specializing in medicine, oncology, and cancer immunotherapy.

Publications per year

1988–1999

6

Publications

6

Phase II study of weekly intravenous recombinant humanized anti-p185HER2 monoclonal antibody in patients with HER2/neu-overexpressing metastatic breast cancer.

José Baselga, Debu Tripathy, John Mendelsohn et al. · Journal of Clinical Oncology · 1996 · 1.4K citations

, , +17

Phase II study of weekly intravenous trastuzumab (Herceptin) in patients with HER2/neu-overexpressing metastatic breast cancer.

José Baselga, Debu Tripathy, J. Mendelsohn et al. · PubMed · 1999 · 300 citations

, , +16

Carbohydrate vaccines in cancer: Immunogenicity of a fully synthetic globo H hexasaccharide conjugate in man

Susan F. Slovin, Govindaswami Ragupathi, Sucharita Adluri et al. · Proceedings of the National Academy of Sciences · 1999 · 253 citations · Full text

, , +17

Phase I trial of a mouse monoclonal antibody against GD3 ganglioside in patients with melanoma: induction of inflammatory responses at tumor sites.

Saroj Vadhan‐Raj, Carlos Cordon‐Cardo, E A Carswell et al. · Journal of Clinical Oncology · 1988 · 153 citations

, , +14

Dose-escalation trial of M195 labeled with iodine 131 for cytoreduction and marrow ablation in relapsed or refractory myeloid leukemias.

Michael Schwartz, Dennis Lovett, Arlene Redner et al. · Journal of Clinical Oncology · 1993 · 131 citations

, , +15

1–5 of 6